How to get patent in Canada?

  In the rapidly changing technology landscape, intellectual property (IP) is one of the most potent weapons. Every smartphone, app, or chip has a thick thicket of patents that set the boundaries of innovation. But over the past two decades, “patent invalidation” has become a dubious strategy — especially for Big Tech titans such as Apple, Samsung, Google, and Microsoft — to squash smaller players or neutralize the heat from competitors. Welcome to the world of global patent wars, where courtroom combat is every bit as fierce as marketplace competition.

 Nexgen Biologics, a California biotech company, had only six weeks to go before they could release their groundbreaking cell preservation technology. Their plans for celebration were short-lived. A routine message from their IP counsel brought the bad news: an initial review had revealed a possible patent infringement problem threatening not just their launch but the existence of the company. This situation — a time-sensitive patent revelation threatening years of R&D investment — repeats itself with chilling regularity throughout the biotech industry. What distinguished Nexgen’s tale from that of innumerable failed start-ups, however, was a single pivotal decision made 18 months prior:  spending money on thorough Freedom-to-Operate (FTO) analysis.